Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

MXCT.US - Current Price

$1.36

Company Information

▼
Company Name
MaxCyte Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US57777K1060
CIK: 0001287098
CUSIP: 57777K106
Currency: USD
Full Time Employees: 114
Phone: 301 944 1700
Website: https://www.maxcyte.com
Fiscal Year End: December
IPO Date: Jul 30, 2021
Description:

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Address:

9713 Key West Avenue, Rockville, MD, United States, 20850

Directors & Officers

▼
Name Title Year Born
Mr. Maher Masoud President, CEO & Executive Director 1975
Mr. Douglas J. Swirsky CFA, CPA Chief Financial Officer 1969
Mr. Jay Gelfman Senior Vice President of Operations NA
Mr. Jack Horgan Senior Vice President of Corporate Development NA
Ms. Ana-Paula Martins Fernandes Senior Vice President of Global Sales NA
Ms. Jill Mayer Senior Vice President of Human Resources NA

Shares Statistics

▼
Shares Outstanding: 106.67M
Shares Float: 96.94M
% Insiders: 177.00%
% Institutions: 7,507.00%
Short % Float: 2.53%

Valuation Metrics

▼
Enterprise Value: $64.98M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $152.54M
EBITDA: $-46.21M
Book Value: $1.69
Earnings/Share: $-0.43
Profit Margin: -132.58%
Operating Margin: -162.41%
ROA (TTM): -13.67%
ROE (TTM): -23.19%
Revenue (TTM): $34.42M
Revenue/Share (TTM): $0.32
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -16.40%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.10 N/A 10,000.00%
Sep 30, 2025 -0.12 -0.11 N/A -591.35%
Jun 30, 2025 -0.12 -0.10 N/A -2,000.00%
Mar 31, 2025 -0.10 -0.13 N/A 2,307.69%
Dec 31, 2024 -0.10 -0.12 N/A 1,666.67%
Sep 30, 2024 -0.11 -0.12 N/A 833.33%
Jun 30, 2024 -0.09 -0.13 N/A 3,076.92%
Mar 31, 2024 -0.09 -0.13 N/A 3,076.92%
Dec 31, 2023 -0.05 -0.07 N/A 2,857.14%
Sep 30, 2023 -0.11 -0.10 N/A -1,000.00%
Jun 30, 2023 -0.10 -0.10 N/A 0.00%
Mar 31, 2023 -0.11 -0.11 N/A 0.00%
Dec 31, 2022 -0.05 -0.07 N/A 2,857.14%
Sep 30, 2022 -0.06 -0.08 N/A 2,500.00%
Jun 30, 2022 -0.08 -0.08 N/A 0.00%
Mar 31, 2022 -0.04 -0.07 N/A 4,285.71%
Dec 31, 2021 -0.05 -0.05 N/A 0.00%
Sep 30, 2021 -0.03 -0.05 N/A 4,000.00%
Jun 30, 2021 -0.05 -0.06 N/A 1,666.67%
Mar 31, 2021 -0.07 -0.10 N/A 3,000.00%
Dec 31, 2020 -0.09 0.00 N/A N/A
Sep 30, 2020 -0.04 0.00 N/A N/A
Jun 30, 2020 -0.04 0.00 N/A N/A
Dec 31, 2019 -0.05 0.00 N/A N/A
Sep 30, 2019 -0.03 0.00 N/A N/A
Jun 30, 2019 -0.03 0.00 N/A N/A
Mar 31, 2019 -0.09 0.00 N/A N/A
Dec 31, 2018 -0.09 0.00 N/A N/A
Sep 30, 2018 -0.04 0.00 N/A N/A
Jun 30, 2018 -0.04 0.00 N/A N/A
Mar 31, 2018 -0.05 0.00 N/A N/A
Dec 31, 2017 -0.05 0.00 N/A N/A
Sep 30, 2017 -0.06 0.00 N/A N/A
Jun 30, 2017 -0.06 0.00 N/A N/A
Mar 31, 2017 -0.05 0.00 N/A N/A
Dec 31, 2016 -0.05 0.00 N/A N/A
Sep 30, 2016 -0.02 0.00 N/A N/A
Jun 30, 2016 -0.02 0.00 N/A N/A
Mar 31, 2016 -0.04 0.00 N/A N/A
Dec 31, 2015 -0.04 0.00 N/A N/A
Sep 30, 2015 -0.40 0.00 N/A N/A
Jun 30, 2015 -0.40 0.00 N/A N/A
Mar 31, 2015 -0.53 0.00 N/A N/A
Dec 31, 2014 -0.53 0.00 N/A N/A
Sep 30, 2014 -1.95 0.00 N/A N/A
Jun 30, 2014 -1.95 0.00 N/A N/A
Mar 31, 2014 -15.30 0.00 N/A N/A
Dec 31, 2013 -15.30 0.00 N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $27.88M $N/A $239.47M $33.22M $206.25M
2023-12-31 $46.51M $N/A $268.27M $36.11M $232.17M
2022-12-31 $11.07M $N/A $286.65M $32.69M $253.97M
2021-12-31 $47.78M $N/A $284.12M $21.22M $262.90M
2020-12-31 $18.76M $N/A $51.78M $18.55M $33.23M
2019-12-31 $15.21M $N/A $29.99M $16.38M $13.60M
2018-12-31 $11.25M $N/A $24.27M $11.99M $12.28M
2017-12-31 $25.34M $N/A $31.40M $11.80M $19.60M
2016-12-31 $11.73M $N/A $16.07M $10.99M $5.08M
2015-12-31 $2.41M $N/A $6.40M $9.48M $-3.08M
2014-12-31 $3.41M $N/A $6.30M $7.95M $-1.65M
2013-12-31 $764.90K $N/A $2.50M $4.05M $-1.54M
2012-12-31 $1.42M $N/A $2.84M $3.43M $-590.70K

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 13, 2025 N/A N/A N/A N/A N/A N/A
Aug 13, 2025 N/A N/A N/A N/A N/A N/A
Aug 13, 2025 N/A N/A N/A N/A N/A N/A
Aug 13, 2025 N/A N/A N/A N/A N/A N/A
Aug 13, 2025 N/A N/A N/A N/A N/A N/A
Jun 25, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A
Mar 18, 2025 N/A N/A N/A N/A N/A N/A
Jan 27, 2025 N/A N/A N/A N/A N/A N/A
Jan 13, 2025 N/A N/A N/A N/A N/A N/A
Dec 26, 2024 N/A N/A N/A N/A N/A N/A
Oct 28, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist